News
Humana said it will invest $1 billion in its Medicare Advantage business following a disclosure the health insurer would add fewer seniors to such plans than expected for 2022.
This story was originally published on Healthcare Dive. To receive daily news and insights, subscribe to our free daily Healthcare Dive newsletter. Humana is the second largest Medicare Advantage ...
Humana will exit its employer group commercial health insurance business to focus on Medicaid, Medicare Advantage and other government-backed business. Newsletters Games Share a News Tip Featured ...
Hosted on MSN24d
Humana holds investor day on Medicare Advantage - MSNHumana, the second-largest Medicare Advantage insurer in the country, is turning to a familiar strategy to boost profitability: encouraging members to attend their annual wellness visits. At the ...
Tara Bannow covers hospitals, providers, and insurers. You can reach Tara on Signal at tarabannow.70. A central theme in Humana’s plan for boosting Medicare Advantage profitability in the future ...
During quarterly earnings calls, Anthem, Humana and WellCare Health Plans indicated intentions to capture greater shares of the growing Medicare Advantage market, Forbes reports. Here are six insights ...
Humana, one of the two biggest players in the Medicare Advantage market, is being hit with high benefit expenses due to high utilization among its members, according to a June 16 filing with the ...
Humana: Medicare Advantage May Fail Without Regulator Intervention, Threatening Core Business Oct. 18, 2024 4:18 PM ET Humana Inc. (HUM) Stock HUM 9 Comments Harrison Schwartz ...
Cigna's Medicare Advantage business segment is projected to draw bids exceeding $3 billion. Cigna boasts fewer than 600,000 Medicare Advantage enrollees as of March. Get ahead of Wall Street ...
For those of us in healthcare, we are humbled by the opportunity to partner with patients to help them solve complex and highly personal challenges. Watching the pandemic unfold, we experienced ...
Humana CEO Bruce Broussard said the payer would stick with its decision to withdraw from the health insurance exchanges despite what happens with the ACA, Reuters reports. 1. Mr. Broussard said the ...
Analysts have recently evaluated Humana and provided 12-month price targets. The average target is $364.33, accompanied by a high estimate of $396.00 and a low estimate of $310.00.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results